This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Jul;48(1):11-13.

doi: 10.1007/s11239-019-01861-6.

Drug-eluting stents versus bare-metal stents with a single month of dual antiplatelet therapy: a trial sequential analysis

Babikir Kheiri¹, Ghassan Bachuwa¹, Deepak L Bhatt²

Affiliations

Affiliations

¹ Department of Internal Medicine, Hurley Medical Center/Michigan State University, Flint, MI, 48503, USA.
² Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. dlbhattmd@post.harvard.edu.

PMID: 30993516
DOI: 10.1007/s11239-019-01861-6

Comment

Drug-eluting stents versus bare-metal stents with a single month of dual antiplatelet therapy: a trial sequential analysis

Babikir Kheiri et al. J Thromb Thrombolysis. 2019 Jul.

. 2019 Jul;48(1):11-13.

doi: 10.1007/s11239-019-01861-6.

Authors

Babikir Kheiri¹, Ghassan Bachuwa¹, Deepak L Bhatt²

Affiliations

¹ Department of Internal Medicine, Hurley Medical Center/Michigan State University, Flint, MI, 48503, USA.
² Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, 75 Francis Street, Boston, MA, 02115, USA. dlbhattmd@post.harvard.edu.

PMID: 30993516
DOI: 10.1007/s11239-019-01861-6

No abstract available

PubMed Disclaimer

Comment on

Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis.
Shah R, Rao SV, Latham SB, Kandzari DE. Shah R, et al. JAMA Cardiol. 2018 Nov 1;3(11):1050-1059. doi: 10.1001/jamacardio.2018.3551. JAMA Cardiol. 2018. PMID: 30383145 Free PMC article.

Similar articles

Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy.
Zemplenyi M, Wei LJ. Zemplenyi M, et al. JAMA Cardiol. 2019 May 1;4(5):494. doi: 10.1001/jamacardio.2019.0546. JAMA Cardiol. 2019. PMID: 30916712 No abstract available.
Quantifying the Treatment Effect of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy-Reply.
Shah R, Rao SV, Kandzari DE. Shah R, et al. JAMA Cardiol. 2019 May 1;4(5):494-495. doi: 10.1001/jamacardio.2019.0556. JAMA Cardiol. 2019. PMID: 30916718 No abstract available.
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
Kereiakes DJ, Yeh RW, Massaro JM, Driscoll-Shempp P, Cutlip DE, Steg PG, Gershlick AH, Darius H, Meredith IT, Ormiston J, Tanguay JF, Windecker S, Garratt KN, Kandzari DE, Lee DP, Simon DI, Iancu AC, Trebacz J, Mauri L; DAPT Study Investigators. Kereiakes DJ, et al. JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026. JACC Cardiovasc Interv. 2015. PMID: 26493248 Clinical Trial.
Use of antiplatelet therapy after percutaneous coronary intervention with bare-metal stents and different types of drug-eluting stents.
Singh T, Cuomo L, Cohen M, Ahmad HA, Aronow WS. Singh T, et al. Curr Clin Pharmacol. 2013 Feb 1;8(1):59-66. Curr Clin Pharmacol. 2013. PMID: 22946865 Review.
Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? All patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy.
Brener SJ. Brener SJ. Circulation. 2015 Jun 2;131(22):2001-9; discussion 2009. doi: 10.1161/CIRCULATIONAHA.114.013279. Circulation. 2015. PMID: 26034082 Review. No abstract available.

See all similar articles

Cited by

Drug-Coated Balloons for De Novo Coronary Artery Lesions: A Meta-Analysis of Randomized Clinical Trials.
Wang D, Wang X, Yang T, Tian H, Su Y, Wang Q. Wang D, et al. Yonsei Med J. 2023 Oct;64(10):593-603. doi: 10.3349/ymj.2022.0606. Yonsei Med J. 2023. PMID: 37727918 Free PMC article.

References

1. JAMA Cardiol. 2018 Nov 1;3(11):1059 - PubMed
1. J Thromb Thrombolysis. 2018 Apr;45(3):432-439 - PubMed
1. JAMA Cardiol. 2018 Nov 1;3(11):1050-1059 - PubMed
1. J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2915-2931 - PubMed
1. Int J Epidemiol. 2009 Feb;38(1):276-86 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer